Search research articles
Contact Us
Filters
Showing results (121-130 of 346) with videos related to
Page
of 35
Sort By:
Leukemia & Lymphoma
|
June 1, 2026
Latency between detectable low-level MRD by next-generation sequencing and overt relapse in ALL: implications for the optimal frequency of MRD monitoring
Trevor Jamison, Elias Jabbour, Omer Karrar, et al.
Blood
|
May 29, 2016
Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Nicholas J Short, Elias Jabbour, Koji Sasaki, et al.
Leukemia & Lymphoma
|
February 2, 2026
Case series: rhabdomyolysis in patients taking isocitrate dehydrogenase inhibitors for myelodysplastic syndrome and relapsed/refractory acute myeloid leukemia
Jacob E Herstein, Kayleigh R Marx, Fadi G Haddad, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 22, 2025
Tyrosine Kinase Inhibitors During Frontline Therapy in Adults With Acute Lymphoblastic Leukemia With ABL-class Rearrangements
Julie Braish, Hagop Kantarjian, Nicholas J Short, et al.
Frontiers in Oncology
|
February 2, 2026
Case Report: FIA plus venetoclax in a patient on hemodialysis
Jacob E Herstein, Kayleigh R Marx, J Michael Savoy, et al.
Archives of Pathology & Laboratory Medicine
|
June 16, 2025
Technical and Clinical Validity of Assessing Measurable Residual Disease by Multicolor Flow Cytometry in an Unselected Acute Myeloid Leukemia Patient Cohort
Sa A Wang, Shaoying Li, Wei Wang, et al.
Leukemia & Lymphoma
|
August 19, 2025
Mortality and relapse dynamics in AML after three years of complete remission
Samuel Urrutia, Wei-Ying Jen, Koji Sasaki, et al.
American Journal of Hematology
|
May 28, 2022
Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia
Shilpa Paul, Hagop Kantarjian, Koji Sasaki, et al.
American Journal of Hematology
|
March 7, 2019
NPM1 mutant variant allele frequency correlates with leukemia burden but does not provide prognostic information in NPM1-mutated acute myeloid leukemia
Hussein A Abbas, Farhad Ravandi, Sanam Loghavi, et al.
American Journal of Hematology
|
August 28, 2024
A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia
Wei-Ying Jen, Elias Jabbour, Nicholas J Short, et al.
Page
of 35
Search research articles
Search
Showing results (121-130 of 346) with videos related to
Sort By:
Page
of 35
Leukemia & Lymphoma
|
June 1, 2026
Latency between detectable low-level MRD by next-generation sequencing and overt relapse in ALL: implications for the optimal frequency of MRD monitoring
Trevor Jamison, Elias Jabbour, Omer Karrar, et al.
Blood
|
May 29, 2016
Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Nicholas J Short, Elias Jabbour, Koji Sasaki, et al.
Leukemia & Lymphoma
|
February 2, 2026
Case series: rhabdomyolysis in patients taking isocitrate dehydrogenase inhibitors for myelodysplastic syndrome and relapsed/refractory acute myeloid leukemia
Jacob E Herstein, Kayleigh R Marx, Fadi G Haddad, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 22, 2025
Tyrosine Kinase Inhibitors During Frontline Therapy in Adults With Acute Lymphoblastic Leukemia With ABL-class Rearrangements
Julie Braish, Hagop Kantarjian, Nicholas J Short, et al.
Frontiers in Oncology
|
February 2, 2026
Case Report: FIA plus venetoclax in a patient on hemodialysis
Jacob E Herstein, Kayleigh R Marx, J Michael Savoy, et al.
Archives of Pathology & Laboratory Medicine
|
June 16, 2025
Technical and Clinical Validity of Assessing Measurable Residual Disease by Multicolor Flow Cytometry in an Unselected Acute Myeloid Leukemia Patient Cohort
Sa A Wang, Shaoying Li, Wei Wang, et al.
Leukemia & Lymphoma
|
August 19, 2025
Mortality and relapse dynamics in AML after three years of complete remission
Samuel Urrutia, Wei-Ying Jen, Koji Sasaki, et al.
American Journal of Hematology
|
May 28, 2022
Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia
Shilpa Paul, Hagop Kantarjian, Koji Sasaki, et al.
American Journal of Hematology
|
March 7, 2019
NPM1 mutant variant allele frequency correlates with leukemia burden but does not provide prognostic information in NPM1-mutated acute myeloid leukemia
Hussein A Abbas, Farhad Ravandi, Sanam Loghavi, et al.
American Journal of Hematology
|
August 28, 2024
A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia
Wei-Ying Jen, Elias Jabbour, Nicholas J Short, et al.
Page
of 35